SARS-CoV uses ACE2 and CD209L receptors in infection

Abstract

Diabetes causes an increase in the expression of Angiotensin-converting enzyme 2 (ACE 2). In fact, the receptor ACE2 is a portal of entry of SARS-CoV. in this discussion, we focus on another receiver, CD209L, which also facilitates entry of SARS-CoV into the cell in diabetic subjects.